Biosynthetic menthol

01Overview and value chain

Markers: [EC: REACH chemical registration (EC 1907/2006) + China API/drug manufacturing licensing (NMPA / Anhui Provincial Drug Administration) | OECD: Industrial biotechnology | Regulator: REACH (EU), NMPA (China)]

L-menthol is a chiral monoterpenoid used across oral care, tobacco, confectionery, pharmaceutical and personal-care products, produced either by catalytic asymmetric synthesis from petrochemical monoterpene precursors or by extraction and chiral resolution of natural mint oil. In 2026 the confirmed commercial activity is capacity expansion of these two conventional routes rather than a dedicated fermentation-based “biosynthetic” originator: BASF commissioned a triple-digit-million-euro world-scale menthol and linalool facility at its Ludwigshafen Verbund site in April 2026, alongside a parallel citral plant at its Zhanjiang, China site; Symrise markets a synthetic-menthol franchise it dates to 50 years of continuous production; and in China, Huangshan Tianmu Mint Pharmaceutical (a subsidiary of the listed Tianmu Pharmaceutical group) had its API drug-manufacturing license for menthol and mint-sucrose oil renewed by the Anhui Provincial Drug Administration through December 2030, while Jiangsu Caiwei Biotechnology supplies food-grade menthol formulated with a hydrophilic-colloid dispersion technology dosed at 0.001-0.5% in gum and beverage applications. Dedicated engineered-yeast fermentation routes to L-menthol (metabolic-pathway and chiral-reductase approaches) remain active in academic literature — RWTH Aachen’s “Waste2Menthol” synthesis route from pulp-and-paper waste, and separate shikimate/terpenoid-pathway yeast-engineering papers — but no company-specific commercial fermentation originator cleared source confirmation in 2026.

The key directions of biosynthetic menthol are:

1. World-scale conventional capacity expansion (World-Scale Menthol/Linalool Production): BASF’s triple-digit-million-euro Ludwigshafen Verbund facility integrating menthol and linalool production with existing aroma-ingredient infrastructure, commissioned April 2026.
2. Synthetic-menthol flavor & fragrance franchises (Synthetic Menthol Flavor & Fragrance Formulation): Symrise’s established synthetic-menthol business, marking 50 years of production and distributed through its flavor and fragrance customer base.
3. NMPA-licensed pharma-grade API manufacturing (Pharma-Grade Menthol API Licensing): Huangshan Tianmu Mint Pharmaceutical’s drug-manufacturing license (menthol and mint-sucrose oil as raw-material drugs), renewed to 2030 by the Anhui Provincial Drug Administration.
4. Food-grade dispersion and formulation technology (Food-Grade Menthol Dispersion Tech): Jiangsu Caiwei’s hydrophilic-colloid dispersion technology enabling precise 0.001-0.5% dosing of menthol in gum, dairy and beverage products.

Sectoral value chain

[petrochemical monoterpene precursors / cultivated mint oil] ──> [catalytic synthesis or steam-distillation extraction]
                                                                                │
                                                                (racemic mixture or crude mint oil)
                                                                                │
                                                                                ▼
[L-menthol, API/food/F&F grade] <─── [chiral resolution and purification] <───┘
                                                                                │
                                                                                ▼
                                                [oral care, tobacco, confectionery, pharma, personal care]

Value chain levels

Cross-cutting technologies of the sector:

• World-scale Verbund integration (World-Scale Menthol/Linalool Production): BASF’s approach of integrating menthol and linalool capacity into the existing Ludwigshafen Verbund, sharing utilities, logistics and upstream feedstock streams across its aroma-ingredients portfolio.
• Chiral resolution and purity control (Pharma-Grade Menthol API Licensing): licensed API production requiring validated chiral-purity and impurity-profile control under NMPA drug-manufacturing standards.
• Hydrophilic-colloid dispersion (Food-Grade Menthol Dispersion Tech): Jiangsu Caiwei’s dispersion technology solving menthol’s poor water-solubility for uniform distribution in dairy and baked-good matrices at 0.001-0.5% dosing.

02US

No US company or research institute cleared source confirmation as a commercial biosynthetic- or conventional-menthol originator in 2026 sourcing; US-linked activity found in this search round was limited to academic and platform-level engineered-yeast terpenoid literature rather than a menthol-specific commercial product.

research gap, engineered-yeast terpenoid literature

• Research gap: no US-headquartered company confirmed a commercial L-menthol product (synthetic or fermentation-route) in 2026 sourcing; industrial biotechnology platform companies active in yeast metabolic engineering (e.g. Yarrowia lipolytica shikimate-pathway work, engineered-yeast limonene biosynthesis from sugarcane molasses) publish on related monoterpene pathways without a menthol-specific commercial claim.
• Regulatory pathway: a US-marketed L-menthol product would clear FDA GRAS (generally recognized as safe) status for food/oral-care use, the same pathway already used by conventional synthetic and natural menthol.

03CN

China hosts two confirmed commercial menthol producers spanning the API/pharmaceutical and food-grade formulation segments — Huangshan Tianmu Mint Pharmaceutical (Anhui) and Jiangsu Caiwei Biotechnology (Jiangsu) — reflecting the country’s traditional strength as the largest grower and processor of Mentha arvensis mint oil.

Huangshan Tianmu, Jiangsu Caiwei, NMPA API licensing

• Huangshan Tianmu Mint Pharmaceutical (Anhui, China): subsidiary of the listed Tianmu Pharmaceutical group; received a renewed drug-manufacturing license from the Anhui Provincial Drug Administration (valid through December 31, 2030) covering raw-material-drug production of menthol and mint-sucrose oil.
• Jiangsu Caiwei Biotechnology (Jiangsu, China): ranked among China’s leading menthol suppliers for its full-chain solution spanning food, pharmaceutical and industrial applications; its hydrophilic-colloid dispersion technology enables uniform menthol distribution in dairy and baked goods at 0.001-0.5% precision dosing, supplying multinational food manufacturers with national-standard-certified, food-grade product.
• NMPA API licensing framework: menthol and mint-sucrose oil manufactured as raw-material drugs in China require a drug-manufacturing license from the provincial drug administration (here, Anhui) under NMPA oversight, distinct from the food-additive registration pathway used for food-grade menthol.

04EU

The EU anchors world-scale conventional menthol production and a long-established synthetic-menthol franchise — BASF (Germany) and Symrise (Germany) — both integrated into broader aroma-ingredients and flavor-and-fragrance portfolios under the REACH chemical-registration regime.

BASF, Symrise, REACH

• BASF (Ludwigshafen, Germany): commissioned a triple-digit-million-euro world-scale menthol and linalool facility at its Ludwigshafen Verbund site in April 2026, integrating the new capacity with existing production technologies and utilities; the announcement paired this with a citral plant commissioning at BASF’s Zhanjiang, China site, extending the same aroma-ingredients investment across both regions.
• Symrise (Holzminden, Germany): markets a synthetic-menthol product line it describes as marking 50 years of continuous production, distributed through its flavor and fragrance customer base alongside its broader scent-and-care portfolio.
• REACH framework: menthol manufactured or placed on the EU market — whether via conventional synthesis or eventual fermentation-route biosynthesis — falls under REACH chemical registration, evaluation and authorisation, the same regime governing its petrochemical precursor inputs.

05Leading companies and research institutes

06Tech stack and innovations

The stack spans conventional production technology under active capacity expansion, rather than a dedicated fermentation platform: world-scale catalytic/Verbund production, licensed chiral-purity API manufacturing, and food-grade dispersion formulation.

1. World-scale Verbund production (World-Scale Menthol/Linalool Production):
   • BASF’s Ludwigshafen facility integrates the new menthol/linalool capacity with existing Verbund utilities and logistics, part of a triple-digit-million-euro investment commissioned April 2026.
   • The same investment round commissioned a parallel citral plant at BASF’s Zhanjiang, China site, linking EU and China aroma-ingredients capacity under one announcement.
2. Chiral resolution and API purity control (Pharma-Grade Menthol API Licensing):
   • Huangshan Tianmu Mint Pharmaceutical’s renewed NMPA drug-manufacturing license (through 2030) requires validated chiral-purity and impurity-profile control for menthol and mint-sucrose oil as raw-material drugs.
   • Purity specifications in the Chinese API-grade market commonly reference 99%+ menthol content with defined organoleptic (needle-crystal, characteristic odor) criteria.
3. Hydrophilic-colloid dispersion technology (Food-Grade Menthol Dispersion Tech):
   • Jiangsu Caiwei’s dispersion technology addresses menthol’s poor water solubility, enabling uniform distribution through dairy and baked-good matrices at 0.001-0.5% dosing without excessive sensory intensity.
   • The same technology base underlies national-standard-certified food-grade supply to multinational food-manufacturing customers.

07Value chains and production pipelines

Industrial pipeline of biosynthetic menthol (REACH / NMPA API)

┌───────────────────────────┐      ┌───────────────────────────┐
│ 1. Feedstock sourcing     │ ───> │ 2. Synthesis /            │
│    (precursor or mint     │      │    extraction              │
│    biomass)               │      │                            │
└───────────────────────────┘      └───────────────────────────┘
                                                   │
                                                   ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 4. API / grade            │ <─── │ 3. Chiral resolution /     │
│    certification           │      │    purification            │
└───────────────────────────┘      └───────────────────────────┘
              │
              ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 5. Formulation & dispersion│ ───> │ 6. End-use application    │
│    (NMPA/food-grade)       │      │    (oral care, pharma)     │
└───────────────────────────┘      └───────────────────────────┘

Stage 1: Feedstock sourcing

Petrochemical monoterpene precursors (citral, myrcene derivatives) feed the catalytic synthesis route at BASF’s Ludwigshafen Verbund; cultivated and wild-harvested Mentha arvensis mint biomass feeds the extraction route used by Chinese processors including Huangshan Tianmu and Jiangsu Caiwei’s supply base.

Stage 2: Synthesis / extraction

Catalytic asymmetric synthesis produces racemic menthol at world-scale integrated sites (BASF’s triple-digit-million-euro Ludwigshafen expansion, commissioned April 2026); alternatively, steam distillation and solvent extraction recover crude mint oil from harvested biomass.

Stage 3: Chiral resolution / purification

The L-menthol enantiomer is separated from racemic synthetic mixtures or crude mint oil via crystallization or chromatographic resolution, yielding purified L-menthol crystal suitable for further grading.

Stage 4: API / grade certification

Purified L-menthol destined for pharmaceutical raw-material use is certified under an NMPA drug-manufacturing license (Huangshan Tianmu’s license, renewed through December 2030 by the Anhui Provincial Drug Administration); material destined for food use is certified to national food-grade standards.

Stage 5: Formulation & dispersion

Certified-grade L-menthol is blended into finished formulations — Jiangsu Caiwei’s hydrophilic-colloid dispersion technology for dairy, bakery and beverage applications at 0.001-0.5% dosing, or Symrise’s flavor-and-fragrance house compounding for its 50-year synthetic-menthol franchise.

Stage 6: End-use application

Finished menthol ingredient is applied across oral care, tobacco, confectionery, pharmaceutical cough/cold preparations and personal-care products, the demand base underlying BASF’s and Symrise’s world-scale and franchise production respectively.